Mint Tower Capital Management B.V. Clovis Oncology, Inc. Transaction History

Mint Tower Capital Management B.V.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 13, 2020	SELL	$3.77 - $11.0 $7,540 - $22,000	-2,000 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$3.93 - $15.35 $393 - $1,535	100 Added 5.26%	2,000 $8,000
Q2 2019 Aug 13, 2019	BUY	$12.81 - $25.67 $24,339 - $48,773	1,900 New	1,900 $0

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of Mint Tower Capital Management B.V., based on Form 13F filings with the SEC.

Stay updated on Mint Tower Capital Management B.V. with notifications on news.